COveRs to impRove AesthetiC ouTcome after Surgery for Chronic subdural haemAtoma by buRr hole trepanation (CORRECT-SCAR): protocol of a Swiss single-blinded, randomised controlled trial

Martin N Stienen, Kevin Akeret, Flavio Vasella, Julia Velz, Elisabeth Jehli, Pierre Scheffler, Stefanos Voglis, Oliver Bichsel, Nicolas Roydon Smoll, Oliver Bozinov, Luca Regli, Menno R Germans, CORRECT-SCAR study group*, David Bellut, Sandra F Dias, Giuseppe Esposito, Jorn Fierstra, Dilek Könü-Leblebicioglu, Niklaus Krayenbühl, Marian C Neidert, Markus Oertel, Carlo Serra, Lennart H Stieglitz, Lazar Tosic, Laurenz Peltenburg-Brechneff, Basil E Grüter, Anna-Sophie Hofer, Alexander Küffer, Philip-Rudolf Rauch, Martina Sebök, Bas van Niftrik, Tristan P C van Doormaal, Martin N Stienen, Kevin Akeret, Flavio Vasella, Julia Velz, Elisabeth Jehli, Pierre Scheffler, Stefanos Voglis, Oliver Bichsel, Nicolas Roydon Smoll, Oliver Bozinov, Luca Regli, Menno R Germans, CORRECT-SCAR study group*, David Bellut, Sandra F Dias, Giuseppe Esposito, Jorn Fierstra, Dilek Könü-Leblebicioglu, Niklaus Krayenbühl, Marian C Neidert, Markus Oertel, Carlo Serra, Lennart H Stieglitz, Lazar Tosic, Laurenz Peltenburg-Brechneff, Basil E Grüter, Anna-Sophie Hofer, Alexander Küffer, Philip-Rudolf Rauch, Martina Sebök, Bas van Niftrik, Tristan P C van Doormaal

Abstract

Introduction: Outcomes rated on impairment scales are satisfactory after burr hole trepanation for chronic subdural haematoma (cSDH). However, the surgery leads to bony defects in the skull with skin depressions above that are frequently considered aesthetically unsatisfactory by the patients. Those defects could be covered by the approved medical devices (burr hole covers), but this is rarely done today. We wish to assess, whether the application of burr hole covers after trepanation for the evacuation of cSDH leads to higher patient satisfaction with the aesthetical result at 90 days postoperative, without worsening disability outcomes or increasing the complication rate.

Methods and analysis: This is a prospective, single-blinded, randomised, controlled, investigator-initiated clinical trial enrolling 80 adult patients with first-time unilateral or bilateral cSDH in Switzerland. The primary outcome is the difference in satisfaction with the aesthetic result of the scar, comparing patients allocated to the intervention (burr hole cover) and control (no burr hole cover) group, measured on the Aesthetic Numeric Analogue scale at 90 days postoperative. Secondary outcomes include differences in the rates of skin depression, complications, as well as neurological, disability and health-related quality of life outcomes until 12 months postoperative.

Ethics and dissemination: The institutional review board (Kantonale Ethikkommission Zürich) approved this study on 29 January 2019 under case number BASEC 2018-01180. This study determines, whether a relatively minor modification of a standard surgical procedure can improve patient satisfaction, without worsening functional outcomes or increasing the complication rate. The outcome corresponds to the value-based medicine approach of modern patient-centred medicine. Results will be published in peer-reviewed journals and electronic patient data will be safely stored for 15 years.

Trial registration number: NCT03755349.

Keywords: Aestheticoutcome; Burr hole cover; Burr hole plate; Chronic subdural hematoma; Complications; Patientsatisfaction; Scar; Trepanation.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Example of skin depression above the burr holes in a male patient in his late 80s, about 2 years following frontal and parietal burr hole trepanation for the evacuation of a large chronic subdural haematoma. The photo was taken with his permission and at this time. He continued to lead an active life. On inquiry, he and his wife confirmed feeling troubled by the well-visible and stigmatising skin depressions.
Figure 2
Figure 2
Illustration of the algorithm of the CORRECT-SCAR trial. cSDH, chronic subdural haematoma; CORRECT-SCAR, COveRs to impRove aesthetiC ouTcome after Surgery for Chronic subdural haemAtoma by buRr hole trepanation.

References

    1. Kolias AG, Chari A, Santarius T, et al. . Chronic subdural haematoma: modern management and emerging therapies. Nat Rev Neurol 2014;10:570–8. 10.1038/nrneurol.2014.163
    1. Maldaner N, Sosnova M, Sarnthein J, et al. . Burr hole trepanation for chronic subdural hematomas: is surgical education safe? Acta Neurochir 2018;160:901–11. 10.1007/s00701-017-3458-8
    1. Im T-S, Lee Y-S, Suh S-J, et al. . The efficacy of titanium Burr hole cover for reconstruction of skull defect after Burr hole trephination of chronic subdural hematoma. Korean J Neurotrauma 2014;10:76–81. 10.13004/kjnt.2014.10.2.76
    1. Vasella F, Akeret K, Smoll NR, et al. . Improving the aesthetic outcome with Burr hole cover placement in chronic subdural hematoma evacuation—a retrospective pilot study. Acta Neurochir 2018;160:2129–35. 10.1007/s00701-018-3659-9 10.1007/s00701-018-3659-9
    1. Velz J, Vasella F, Akeret K, et al. . Patterns of care: burr-hole cover application for chronic subdural hematoma trepanation. Neurosurg Focus 2019;47:E14 10.3171/2019.8.FOCUS19245
    1. Funk W, Podmelle F, Guiol C, et al. . Aesthetic satisfaction scoring - introducing an aesthetic numeric analogue scale (ANA-scale). J Craniomaxillofac Surg 2012;40:439–42. 10.1016/j.jcms.2011.07.018
    1. Schulz KF, Altman DG, Moher D, et al. . Consort 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c332 10.1136/bmj.c332
    1. Stienen MN, Smoll NR, Fung C, et al. . Home-Time as a surrogate marker for functional outcome after aneurysmal subarachnoid hemorrhage. Stroke 2018;49:3081–4. 10.1161/STROKEAHA.118.022808
    1. Stienen MN, Serra C, Stieglitz LH, et al. . UniversitatsSpital Zurich: 80 years of neurosurgical patient care in Switzerland. Acta neurochirurgica 2017.
    1. Kang H. The prevention and handling of the missing data. Korean J Anesthesiol 2013;64:402–6. 10.4097/kjae.2013.64.5.402
    1. White IR, Horton NJ, Carpenter J, et al. . Strategy for intention to treat analysis in randomised trials with missing outcome data. BMJ 2011;342:d40 10.1136/bmj.d40
    1. Lillie EO, Patay B, Diamant J, et al. . The n-of-1 clinical trial: the ultimate strategy for individualizing medicine? Per Med 2011;8:161–73. 10.2217/pme.11.7
    1. Kravitz RL, Duan N, the DEcIDE Methods Center N-of-1 Guidance Panel (Duan N EI, Gabler NB, Kaplan HC, Kravitz RL, Larson EB, Pace WD, Schmid CH, Sim I, Vohra S). AHRQ Publication No. 13(14)-EHC122-EF . Design and Implementation of N-of-1 Trials: A User’s Guide. Rockville, MD: Agency for Healthcare Research and Quality, 2014.
    1. Gautschi OP, Stienen MN, Corniola MV, et al. . Assessment of the minimum clinically important difference in the timed up and go test after surgery for lumbar degenerative disc disease. Neurosurgery 2017;80:380–5.

Source: PubMed

3
Abonneren